Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Should You Buy?

Hypermarcas (OTCMKTS:HYPMY) shares gapped up before the market opened on Tuesday . The stock had previously closed at $4.12, but opened at $4.2725. Hypermarcas shares last traded at $4.35, with a volume of 234 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Hypermarcas currently has an average rating of “Buy”.

Hypermarcas Stock Up 0.5%

The stock has a fifty day simple moving average of $4.12 and a 200-day simple moving average of $4.29. The company has a market capitalization of $3.01 billion, a P/E ratio of 8.54 and a beta of 0.70.

Hypermarcas (OTCMKTS:HYPMY) last posted its earnings results on Thursday, August 6th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%. Analysts predict that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.